Analyst
MedTech Leader
Equibles does not estimate personal net worth.
Tim Schmid is recorded as Analyst at MedTech Leader. Tim Schmid has spoken on 2 earnings calls across 1 company, most recently for Johnson & Johnson on October 15, 2024. The companies whose calls Tim Schmid spoke on are classified in the Healthcare sector.
“We're pleased with the 6.4% operational growth for the quarter and 5.7% for the full year. Our results highlight the success of our strategic shift into higher-growth, higher-margin categories, particularly in cardiovascular.”
“I want to emphasize that we are fully committed to achieving solid growth for the full year of 2024. Regarding the second quarter of 2024, it was more challenging for us than anticipated.”
MedTech Leader
Analyst
Source not stated
Drug Manufacturers - General · Healthcare
